glp-1 alcohol reduction GLP-1s tied to lower intake for adults with overweight, obesity GLP‐1 Receptor Agonists for Treating

We carefully evaluate each patients medical history to rule out contraindications like medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2

Audio tones are delivered via customized Bluetooth headphones

A phase 2 trial has begun for ASC30 in its oral form to treat diabetes, and the drug demonstrated a 5.4%, 7%, and 7.7% decline in weight in participants who were given 20 mg, 40 mg, and 60 mg doses of the drug, respectively, in 13 weeks

It was also an early observation that a higher dose of GLP-1 is needed to produce satiety and reduced food intake than to the antidiabetic effect, so a low dose GLP-1 analog could be used to study weight loss independent effects of GLP-1

Fluids and electrolytes: this is hugely underrated

But as the hype grows, so do the questions: whos using them, what are they saying about their experiences, and how is this trend reshaping the conversation around health and body image in Hollywood